This review examines the role of monomeric CRP (mCRP) as a mediator of ongoing inflammation in obesity and discusses the mechanisms through which it contributes to endothelial dysfunction, immune activation, and metabolic changes. This evidence concerns the gene CRP and endothelial dysfunction.